# GRYT Health, Inc

Increasing access to new cancer treatments

- Canonical URL: https://wefunder.com/grythealth
- Entity ID: wefunder:company:131577
- Last updated: 2026-06-04T05:02:54Z
- Generated at: 2026-06-04T09:18:37Z

## Quick facts
- Over $12 million booked revenue from 20 pharmaceutical and biotech companies
- Founded by cancer survivors and caregivers
- Established patient community with 50 million interactions to date
- $5 million in projected sales pipeline with 23 treatment development clients
- $13.4 billion annual TAM across patient insights, clinical trial recruiting, & treatment marketing
- New FDA requirements make Gryt's services critical
- $5.5 million invested from 18 investors and 4 funds, including The Omidyar Group (founder of eBay)
- Team of industry experts from pharma, Wall Street, tech, research, and patient advocacy

## Active fundraises
- wefunder:fundraise:81222: 4(a)(6) successful (USD)
- wefunder:fundraise:81223: 4(a)(6) successful (USD)

## Story
Gryt Health (‘grit’) amplifies voices to improve health outcomes. Gryt is a healthtech company owned by survivors and caregivers. By always putting the patient experience first, we work to improve medicine development, access to equitable care and outcomes for all. Visit grythealth.com to learn more.Through our innovative, patient engagement platform, Gryt provides clinical trial patient activation, patient experience research, and patient engagement services to the majority of the Top 10 global pharmaceutical companies. Additionally, we work with clinical research organizations, life sciences and biotech companies who are leading cutting edge new treatment development.View slides in a new windowSourceFuture projections are not guaranteedFuture projections are not guaranteedJoin the CommunityShare with your loved ones

## FAQ
1. **Can you share your thoughts on how often you will update us on how things are progressing with your goals and business plan? Secondly, do you intend to file the annual report with the SEC? Thanks for your feedback.**
   - Hello Eric. Thanks for your questions. Yes, we file the annual SEC requirement. We do a detailed quarterly update, as well as share significant achievements and goals as they happen. We value your engagement.
2. **So is the revenue model, "finder fees" paid by bio/pharmaceutical companies for finding patients to participate in research studies?**
   - Hi LD. Thanks for your question. The answer is no to that. As a team of survivors and caregivers ourselves, we have two service lines. "Empowerment programs" are where we invite patients to share their experience and perspective for other patients and healthcare providers to learn from. We co-create these programs with the people living the experience and have developed 250 to-date. "Research programs" are where our team develops the methodology & questions with the client, invites patien...

## Team
- David Craig (Board Member & CEO)
- Shelley Nolden (Board Chair & Angel Investor)
- Brad Love (Board Member & Chief Culture Officer)
- Bill Walsh (Chief Financial Officer)
- Uma Rana (Chief of Strategic Partnerships)
- David Aleksandrowicz (Chief Information Officer)
- Sheila Thorne (Board Member)
- Guy Boike, MD (Board Member)
- Gryt Staff (Staff)

## Q&A
- Q: So is the revenue model, "finder fees" paid by bio/pharmaceutical companies for finding patients to participate in research studies?
  - A: Hi LD. Thanks for your question. The answer is no to that. As a team of survivors and caregivers ourselves, we have two service lines. "Empowerment programs" are where we invite patients to share their experience and perspective for other patients and healthcare providers to learn from. We co-create these programs with the people living the experience and have developed 250 to-date. "Research programs" are where our team develops the methodology & questions with the client, invites patients to participate with us and then we publish or provide the learnings to our clients. We've had 20 posters at conferences and publications in leading journals to help improve understanding and care for patients. Let me know if you'd like examples of either of these. We'd be honored to share them. Adding a press release from one of our ongoing programs: https://news.bms.com/news/details/2021/Bristol-Myers-Squibb-and-GRYT-Health-Evolve-Virtual-Patient-Advocacy-Experience/default.aspx
- Q: Can you share your thoughts on how often you will update us on how things are progressing with your goals and business plan? Secondly, do you intend to file the annual report with the SEC? Thanks for your feedback.
  - A: Hello Eric. Thanks for your questions. Yes, we file the annual SEC requirement. We do a detailed quarterly update, as well as share significant achievements and goals as they happen. We value your engagement.
- Q: Hello Gryt Health Team, I’m Zac Stahlhut with D3VC. We specialize in investment crowdfunding and are impressed by your mission to amplify patient voices and improve health outcomes. Your partnerships with top pharmaceutical and biotech companies are compelling. Could you share more about your plans for scaling the business, particularly given the challenges of driving growth on the pharmacy side? Additionally, how do you see your relationships with biotech and pharmaceutical companies evolving to sustain and expand your impact? Thanks!
- Q: I dont fully understand the business model of your Empowerment programs, can you share in a bit more detail? What is the projected split in revenue from the two service models you use in 2025 and in 2030 (the other being Research programs)?